CureVac NV
NASDAQ:CVAC
CureVac NV
NASDAQ:CVAC
Price:
4.66
USD
Market Closed
Market Cap:
$1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
CureVac NV
NASDAQ:CVAC
|
DE |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
BR |
|
Eenergy Group PLC
LSE:EAAS
|
UK |
|
K
|
Kraft Heinz Co
BMV:KHC
|
US |
|
D
|
Dexcom Inc
SWB:DC4
|
US |
|
8
|
888 Holdings PLC
XMUN:C8V
|
GI |
|
Dr Ing hc F Porsche AG
XETRA:P911
|
DE |
|
First Citizens BancShares Inc (Delaware)
NASDAQ:FCNCA
|
US |
|
Dufry AG
OTC:DUFRY
|
CH |
|
A
|
AGC Inc
DUS:SHJ
|
JP |
|
Commercial Metals Co
NYSE:CMC
|
US |
|
B
|
Beigene Ltd
XMUN:49B
|
KY |
|
Everspin Technologies Inc
NASDAQ:MRAM
|
US |
|
T
|
Thai Airways International PCL
SET:THAI
|
TH |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CVAC's stock price target?
Not Available
CVAC does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for CureVac NV?
Projected CAGR
-22%
-22%
Over the last 5 years, the compound annual growth rate for Revenue has been 98%. The projected CAGR for the next 4 years is -22%.
What is the Operating Income forecast for CureVac NV?
Projected CAGR
-27%
-27%
The compound annual growth rate for Operating Income over the next 4 years is -27%.
